RetinalGenix Technologies (RetinalGenix Technologies) Pre-Tax Income : $-3.73 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is RetinalGenix Technologies Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. RetinalGenix Technologies's pretax income for the three months ended in Mar. 2024 was $-2.15 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.73 Mil. RetinalGenix Technologies's pretax margin was %.

RetinalGenix Technologies Pre-Tax Income Historical Data

The historical data trend for RetinalGenix Technologies's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RetinalGenix Technologies Pre-Tax Income Chart

RetinalGenix Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

-2.08

-2.18

-3.91

-2.09

RetinalGenix Technologies Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial										-0.51	-0.35	-0.69	-0.54	-2.15

Competitive Comparison of RetinalGenix Technologies's Pre-Tax Income

For the Medical Devices subindustry, RetinalGenix Technologies's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RetinalGenix Technologies's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RetinalGenix Technologies's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where RetinalGenix Technologies's Pre-Tax Income falls into.

RetinalGenix Technologies Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

RetinalGenix Technologies's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.087	+	0	+	-0.004	+	0	+	0
	=	-2.09

RetinalGenix Technologies's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.145	+	0	+	-0.001	+	0	+	0
	=	-2.15

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.73 Mil.

RetinalGenix Technologies (OTCPK:RTGN) Pre-Tax Income Explanation

RetinalGenix Technologies's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-2.146	/	0
	=	%

RetinalGenix Technologies Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of RetinalGenix Technologies's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

RetinalGenix Technologies (RetinalGenix Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RetinalGenix Technologies Inc (OTCPK:RTGN) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

1450 North McDowell Boulevard, Suite 150, Petaluma, CA, USA, 94954

Website

https://www.retinalgenix.com

RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: (1) Retinal Imaging Screening Device (RetinalGenixTM), being designed as a portable, high-resolution retinal imaging Diabetic screening system providing a 200-degree field of view without requiring pupil dilation; and (2) RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available 24/7.